Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease

• Published in: Annals of Nuclear Cardiology 2022, Vol.8(1), pp.21-29
• Main Authors: Ohira, Hiroshi, deKemp, Robert, Kadoya, Yoshito, Renaud, Jennifer, Stewart, Duncan J., Davies, Ross A., Chandy, George, Dominguez, Vladamir Contreras, Pugliese, Carolyn, Dunne, Rosemary, Beanlands, Rob, Mielniczuk, Lisa
• Format: Article
• Language: English
• Subjects: 18F-fluorodeoxyglucose positron emission tomography; Glucose metabolism; Glycolysis; Original; Pulmonary arterial hypertension; Pulmonary hypertension due to left heart disease; Remodeled pulmonary vasculature
• ISSN: 2189-3926; 2424-1741
• DOI: 10.17996/anc.22-00151

Aim: Previous studies have demonstrated increased glucose uptake by 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in lung parenchyma in animal models or small pulmonary arterial hypertension (PAH) cohorts. However, it is not well known whether increased FDG uptake in the lung is a unique phenomenon in PAH or whether elevated pulmonary artery pressure (PAP) induces FDG uptake. Methods and results: Nineteen patients with PAH, 8 patients with pulmonary hypertension due to left heart disease (PH-LHD), and 14 age matched control subjects were included. All PH patients underwent right heart catheterization and FDG-PET. The mean standard uptake value (SUV g/mL) of FDG in each lung was obtained and average values of both lungs were calculated as mean lung FDG SUV. The correlation between hemodynamics and mean lung FDG SUV was also analyzed in PH patients. Mean PAP (mPAP) was not significantly different between PAH and PH-LHD (45 ± 11 vs 43 ± 5 mmHg, p=0.51). PAH patients demonstrated significantly increased mean lung FDG SUV compared with PH-LHD and controls (PAH: 0.76 ± 0.26 vs PH-LHD: 0.51 ± 0.12 vs controls: 0.53 ± 0.16, p=0.0025). The mean lung FDG SUV did not correlate with mPAP either in PAH or PH-LHD. Conclusion: PAH is associated with increased lung FDG uptake indicating increased glucose utilization in the lung. This may represent metabolic shift to glycolysis and/or active inflammation in the remodeled pulmonary vasculature, and is observed to a greater extent in PAH than in patients with PH secondary to LHD and control subjects without PH.